Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Newly Diagnosed Pulmonary TB Patients in Tanzania

Nutritional Supplementation Increases Rifampin Exposure among Tuberculosis Patients Coinfected with HIV

(2014) Kidola Jeremiah et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A Four-Month Gatifloxacin-Containing Regimen for Treating Tuberculosis

(2014) Corinne S. Merle et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pharmacokinetics of First-Line Tuberculosis Drugs in Tanzanian Patients

(2013) Alma Tostmann et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Isoniazid, rifampicin and pyrazinamide plasma concentrations 2 and 6 h post dose in patients with pulmonary tuberculosis

(2013) F. Fahimi et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Pharmacokinetics and serum concentrations of antimycobacterial drugs in adult Turkish patients

(2013) A. Babalık et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Serum Drug Concentrations Predictive of Pulmonary Tuberculosis Outcomes

(2013) J. G. Pasipanodya et al.   JOURNAL OF INFECTIOUS DISEASES

TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS

(2013) Lanfranco Fattorini et al.   Mediterranean Journal of Hematology and Infectious Diseases

Performance of Methods for Handling Missing Categorical Covariate Data in Population Pharmacokinetic Analyses

(2012) Ron J. Keizer et al.   AAPS Journal

Reduced Antituberculosis Drug Concentrations in HIV-Infected Patients Who Are Men or Have Low Weight: Implications for International Dosing Guidelines

(2012) Helen McIlleron et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Meta-Analysis of Clinical Studies Supports the Pharmacokinetic Variability Hypothesis for Acquired Drug Resistance and Failure of Antituberculosis Therapy

(2012) Jotam G. Pasipanodya et al.   CLINICAL INFECTIOUS DISEASES

Full-Gene-Sequencing Analysis of N-Acetyltransferase-2 in an Adult Indian Population

(2012) Ashwini V. Tilak et al.   Genetic Testing and Molecular Biomarkers

Study of NAT2 Gene Polymorphisms in an Indian Population

(2012) Neera Singh et al.   Molecular Diagnosis & Therapy

Population Pharmacokinetics of Ethambutol in South African Tuberculosis Patients

(2011) Siv Jönsson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Multidrug-Resistant Tuberculosis Not Due to Noncompliance but to Between-Patient Pharmacokinetic Variability

(2011) Shashikant Srivastava et al.   JOURNAL OF INFECTIOUS DISEASES

A systematic review of pharmacokinetics studies in children with protein-energy malnutrition

(2010) Kazeem A. Oshikoya et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Importance of Shrinkage in Empirical Bayes Estimates for Diagnostics: Problems and Solutions

(2009) Radojka M. Savic et al.   AAPS Journal

Isoniazid, Rifampin, Ethambutol, and Pyrazinamide Pharmacokinetics and Treatment Outcomes among a Predominantly HIV‐Infected Cohort of Adults with Tuberculosis from Botswana

(2009) Sekai Chideya et al.   CLINICAL INFECTIOUS DISEASES

Worldwide distribution of NAT2 diversity: Implications for NAT2 evolutionary history

(2008) Audrey Sabbagh et al.   BMC GENETICS

Mechanism-Based Concepts of Size and Maturity in Pharmacokinetics

(2007) B.J. Anderson et al.   Annual Review of Pharmacology and Toxicology